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Background: Ethnic-specific differences in insulin resistance (IR) are well described but the underlying mechanisms
are unknown. Adiponectin is an insulin sensitizing adipocytokine that circulates as multiple isoforms, with high
molecular weight (HMW) adiponectin associated with greatest insulin sensitivity. The objective of this study is to
determine if plasma total and HMW adiponectin concentrations underlie ethnic-specific differences in IR.
Methods: Healthy Canadian Aboriginal, Chinese, European, and South Asian adults (N = 634) were assessed for
sociodemographics; lifestyle; fasting plasma insulin, glucose, and total and HMW adiponectin; and adiposity
measures [BMI, waist circumference, waist-to-hip ratio, percent body fat, and subcutaneous and visceral adipose
tissue (quantified by computed tomography)]. The homeostasis model assessment-insulin resistance (HOMA-IR)
assessed IR.
Results: South Asians had the greatest HOMA-IR, followed by Aboriginals, Chinese, and Europeans (P < 0.001).
Plasma total and HMW adiponectin concentrations were lower in Chinese and South Asians than Aboriginal and
Europeans (P < 0.05). Total and HMW adiponectin were inversely associated with HOMA-IR (P < 0.001). Ethnicity
modified the relationship between HMW adiponectin and HOMA-IR with stronger effects observed in Aboriginals
(P = 0.001), Chinese (P = 0.002), and South Asians (P = 0.040) compared to Europeans. This was not observed for total
adiponectin (P = 0.431). At mean total adiponectin concentrations South Asians had higher HOMA-IR than Europeans
(P < 0.001).
Conclusions: For each given decrease in HMW adiponectin concentrations a greater increase in HOMA-IR is observed
in Aboriginals, Chinese, and South Asians than Europeans. Ethnic-specific differences in HMW adiponectin may account
for differences in IR.
Keywords: High molecular weight adiponectin, Ethnicity, Insulin resistance, Visceral adipose tissueIntroduction
Insulin resistance (IR) plays an important role in the
etiology of type 2 diabetes [1]. Rates of type 2 diabetes
and IR are increasing in certain ethnic populations, such
as Aboriginal, Chinese, and South Asian compared to
European populations [2-4]. However the underlying
mechanisms accounting for these increased rates are
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article, unless otherwise stated.Adiponectin is an insulin-sensitizing adipocytokine
that may contribute to ethnic-specific differences in IR.
Circulating adiponectin concentrations are inversely pro-
portional to adiposity [5], and adiponectin circulates as
multiple isoforms characterized as low, medium, and
high molecular weight (HMW), with the HMW isoform
being the most abundant and demonstrating the greatest
insulin sensitizing properties [6,7].
Few studies have explored ethnic-specific differences
in the relationship between adiponectin and IR and
the findings have been inconsistent. One investigation
reported no relationship in South Asian and European
South Africans [8]. Whereas others observed a strongerd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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centrations and IR in Europeans than in South Asians
[9] and a stronger relationship in South Asian and
Aboriginals compared to Chinese and Europeans [10].
However, these studies only considered surrogate mea-
sures of adiposity, such as BMI or waist circumference,
when assessing the relationship between adiponectin
and IR, which may account for the discrepant findings.
Further studies are required that consider body fat
distribution, especially visceral adipose tissue (VAT),
given that VAT is strongly associated with IR [11] and
VAT deposition differs according to ethnicity [12].
Furthermore, despite the evidence of ethnic-specific
differences in body fat distribution [12] little is known
regarding ethnic-specific differences in the relationship
between adiposity and adiponectin. Most prior studies
have only considered BMI and waist circumference
[10,13,14]. Direct measures of adiposity have rarely been
utilized and were predominantly explored in African,
Caucasian, and Hispanic American populations [15,16].
Less is known about the relationship between adiposity
and adiponectin in other ethnic groups like Aboriginals,
Chinese, and South Asians and whether it differs from
that of Europeans.
The objectives of this study are: i) to explore ethnic-specific
differences in the relationship between adiposity (body
composition and body fat distribution) and plasma total
and HMW adiponectin concentrations; and ii) to investi-
gate whether ethnicity modifies the relationship of plasma
total and HMW adiponectin concentrations with IR inde-
pendently of visceral adiposity in a multi-ethnic population
of Aboriginals, Chinese, Europeans, and South Asians.
Methods
Study participants and assessments
Study participants were recruited as part of the Multicul-
tural-Community Health Assessment Trial (M-CHAT)
[17]. As previously described [12], the cohort includes ap-
parently healthy men and women (aged 30 to 65 years old)
who were of exclusive European (continental Europe,
Ireland, and the United Kingdom), Chinese (China, Hong
Kong, and Taiwan), Aboriginal (reserve and non-reserve
residents), or South Asian (Bangladesh, India, Nepal,
Pakistan, and Sri Lanka) descent living in and around
Vancouver, Canada. Only those study participants of Ab-
original descent with at least 3 grandparents of exclusive
Aboriginal origin were included in the study due to high
prevalence of mixed ethnic origins in Aboriginal popula-
tions. At the time of recruitment and enrolment in the
study, participants had no known cardiovascular disease or
type 1 or 2 diabetes diagnoses and must have had a stable
body weight in the past 3 months (no more than 2 kg
of body weight lost or gained). For non-Aboriginals, im-
migrants (who have lived in Canada for more than 3 yearsto allow for acculturation) or first or second generation
Canadians were included. The recruitment for study partic-
ipants was done in such a way that there is an equal re-
presentation of participants with healthy, overweight,
and obese BMI in each ethnic group. The study was ap-
proved by the University of British Columbia, Children and
Women’s Health Centre of British Columbia, Providence
Health Care, and Simon Fraser University Research Ethics
Boards. All study participants provided informed consent.
Participants were assessed for age, sex (self-report),
sociodemographics (education and income levels), family
history of type 2 diabetes, and lifestyle factors (smoking
status). Total daily energy intakes were quantified by
collecting a 3-d food record and analyzed by a registered
dietitian using commercially available software (Food
Processor SQL software, ESHA, Salem, OR). Leisure-
time physical activity was assessed as the average minutes
per week of activity over the previous year (self-report)
as previously described [12].
Assessment of insulin resistance
Insulin resistance was calculated using the previously
validated homeostasis model assessment of insulin re-
sistance (HOMA-IR) [18]. Fasting plasma glucose con-
centrations were determined by a glucose hexokinase II
method using an ADVIA 1650 analyzer (Bayer Health
Care, Morristown, NJ). Fasting plasma insulin concen-
trations were quantified by a commercial ELISA assay
using Immulite 2500 analyzer (Diagnostic Products, Los
Angeles, CA). Coefficients of variations for intra- and
inter-assay precision for were less than 7.4%.
Adiposity and body fat distribution
Body mass index was calculated by body weight (kg)/
height (m)2. Waist circumference (WC) was measured
by taking the average of two readings at the point of
maximal narrowing. Hip circumference was recorded as
the mean of two measures taken at the point of maximal
gluteal protuberance from the lateral view over under-
garments. Waist/hip ratio (WHR) was calculated by
dividing WC by hip circumference. Total body fat was
measured by dual-energy X-ray absorptiometry with a
Norland XR-36 scanner (Norland Medical Systems,
White Plains, NY). The percentage of total body fat was
calculated by dividing total body fat by total body mass.
A computed tomography scan was used to take a single
10 mm-thick cross-sectional slice at the lumbar 4/5
(L4/L5) of the inter-vertebral disc to quantify total
abdominal adipose tissue and VAT. Surface area of the
scan was read using the CTi Advantage Scanner (GE,
Milwaukee, WI) and the computation of surface areas
were performed using SliceOmatic v.4.2. (Tomovision,
Montreal). Total abdominal adipose tissue is defined as
the total area in cm2 within an attenuation range of
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the L4/L5 cross-sectional slice image. VAT is the total
area within the aforementioned attenuation range that
falls within the abdominal wall. Subcutaneous adipose
tissue (SAT) was calculated as the difference between
total abdominal adipose tissue and VAT.
Quantification of plasma adiponectin concentrations
Plasma total and HMW adiponectin concentrations were
quantified using a commercially available ELISA (ALPCO
Diagnostics, Salem, NH). HMW adiponectin concentra-
tions were quantified by pretreating plasma with proteinase
K, which selectively digests low and medium molecular
weight adiponectin. The inter-assay (between plates) coeffi-
cient of variability (CV) was 6.15% and the intra-assay
CV was 2.4%.
Statistical analyses
Of the 822 potentially available M-CHAT study partici-
pants, we excluded 188 because of lack of information
on HOMA-IR, total- or HMW adiponectin, which left
634 individuals for our analyses. Distribution of continu-
ous variables was explored for normality, and variables
that were not normally distributed (HOMA-IR, total-
and HMW-adiponectin, VAT, SAT, physical activity)
were natural logarithm (ln) transformed. Continuous
variables are presented as means (95% confidence inter-
val [CI]) or geometric means (95% CI) if not normally
distributed. Ethnic differences in categorical variables
were explored using Chi-square test. The difference in
continuous variables was investigated by analysis of
variance (ANOVA) or general linear modeling where the
analyses were controlled for age and sex. Post hoc pair-
wise comparisons were performed using Bonferroni tests
to adjust for multiple comparisons.
Linear regression models were used to determine the
relationship between adiposity measures (BMI, WC,
waist/hip ratio, percent total body fat, SAT and VAT; in-
dependent variables) and total- and HMW- adiponectin
(dependent variables). Separate models were used for
each adiposity variable and each of the adiponectin vari-
ables, while adjusting for covariates (age, sex, ethnicity,
education, smoking status, physical activity, and total
dietary energy intake). To explore whether ethnicity
modifies the relationship between adiposity and adipo-
nectin, we investigated the interactions of ethnicity with
each of the adiposity measures. We found that ethnicity
did not modify the relationship of adiposity with either
total adiponectin or HMW adiponectin (p > 0.05 for all
ethnicity by adiposity interactions). Furthermore, given
the sex differences in body fat accumulation, we
additionally explored whether sex modifies the relation-
ship of adiposity with total and HMW adiponectin.
Given that all interactions were not significant (p > 0.05for all), the relationship between adiposity and adiponec-
tin was explored on a total sample.
The relationship between total and HMW adiponectin
(independent variables) and HOMA-IR (dependent vari-
able) was examined using linear regression. We explored
interactions of ethnicity with both total and HMW adi-
ponectin in order to explore whether ethnicity modifies
the relationship between adiponectin and IR. While eth-
nicity was found not to modify the association between
total adiponectin and IR (ethnicity by total adiponectin
interaction, p = 0.431), the ethnicity by HMW adiponec-
tin interaction was found significant (p = 0.010). There-
fore, the relationship between total adiponectin and IR
was explored on a total sample after adjusting for ethni-
city and other covariates of interest (age, sex, family
history of diabetes mellitus, education, smoking status,
physical activity, total dietary energy intake, BMI and
WHR). Ethnic specific differences in the relationship be-
tween HMW adiponectin and IR were also explored
using linear regression including the interaction term and
adjusting for the above-mentioned covariates. To evaluate
whether the association of total- and HMW- adiponectin
concentrations with HOMA-IR was independent of VAT,
models were additionally adjusted for VAT.
All regression models were checked for multicolinear-
ity; variance inflation indices and tolerance statistics
were well below 10 and above 0.2, respectively, indicat-
ing that there was no collinearity in our data. Statistical
analyses were performed using Statistical Package for
Social Sciences (IBM SPSS version 19). Results are
considered significant if p < 0.05 (two-sided).
Results
Study participant characteristics
Significant ethnic-specific differences in age, education,
current smoking, physical activity, dietary energy intake,
measures of adiposity, plasma glucose concentrations, and
HOMA-IR were observed (Table 1). Specifically, Chinese
and Europeans were significantly older, had a higher level
of formal education, and higher dietary total energy intake
compared to Aboriginals and South Asians. Furthermore,
Aboriginals and Europeans were more likely to be current
smokers, but engage in greater physical activity than
Chinese and South Asians. Aboriginals had significantly
higher BMI, WC, and WHR compared to the other ethnic
groups, whereas Chinese participants had the lowest BMI
and WC. Percent body fat, VAT, SAT, plasma insulin
concentrations, and HOMA-IR were significantly hig-
her among Aboriginals and South Asians compared to
Chinese and Europeans (P < 0.05 for all).
Adiponectin, ethnicity, and insulin resistance
Total and HMW adiponectin concentrations were simi-
lar in Aboriginals and Europeans and significantly higher
Table 1 Characteristics of study participants by ethnic group
Aboriginal (n = 142) Chinese (n = 163) European (n = 164) South Asian (n = 165) Overall p value
Age (years) 45.7 (44.4-47.1) 48.1 (46.7-49.4) 51.1 (49.8-52.4) 45.1 (43.8-46.4) < 0.001 b, d, e, f
Females 75 (52.8%) 90 (55.2%) 78 (47.6%) 83 (50.3%) 0.550
Education < 0.001
High school or less 55 (38.7%) 53 (32.5%) 33 (20.1%) 68 (41.2%)
More than high school 87 (61.3%) 110 (67.5%) 131 (79.9%) 97 (58.8%)
Current smoker 41 (28.9%) 6 (3.7%) 13 (7.9%) 6 (3.6%) < 0.001
Physical activity (min/week) †* 288.3 (240.6-345.5) 162.1 (136.6-192.5) 247.6 (208.9-293.5) 145.5 (122.6-172.4) < 0.001 a, c, d, f
Diet (total energy, kcals) † 1821 (1725–1918) 2010 (1923–2097) 2100 (2012–2188) 1755 (1665–1845) < 0.001 a, b, e, f
BMI (kg/m2)† 29.2 (28.4-29.9) 25.7 (25.0-26.4) 27.7 (27.0-28.4) 27.7 (27.1-28.4) < 0.001 a-e
WC (cm) † 95.7 (94.0-97.4) 83.5 (81.9-90.8) 89.2 (87.6-90.8) 88.7 (87.1-90.3) < 0.001 a-e
WHR† 0.94 (0.93-0.95) 0.88 (0.87-0.88) 0.87 (0.86-0.88) 0.89 (0.88-0.90) < 0.001 a-c
Percent body fat (%)† 35.0 (33.9-36.0) 30.8 (29.8-31.7) 31.9 (31.0-32.9) 36.4 (35.4-37.4) < 0.001 a, b, e, f
VAT (cm2)†* 117.6 (109.1-126.8) 92.4 (86.2-99.1) 95.8 (89.2-102.8) 118.5 (110.5-127.1) < 0.001 a, b, e, f
SAT (cm2)†* 308.3 (287.4-330.6) 212.3 (199.1-226.6) 260.1 (243.5-277.8) 299.8 (280.9-319.9) < 0.001 a, b, d-f
Glucose (mmol/L) †* 5.25 (5.15-5.35) 5.27 (5.18-5.37) 5.10 (5.01-5.20) 5.35 (5.25-5.45) < 0.001 f
Insulin (μU/mL) †* 72.60 (66.35-79.51) 60.70 (55.76-66.02) 57.69 (52.93-62.87) 77.71 (71.38-84.61) < 0.001 a, b, e, f
HOMA-IR†* 2.44 (2.21-2.70) 2.05 (1.86-2.25) 1.88 (1.71-2.07) 2.66 (2.42-2.92) < 0.001 b, e, f
Total adiponectin (μg/mL) †* 5.17 (4.80-5.56) 4.15 (3.88-4.45) 5.18 (4.83-5.56) 4.41 (4.12-4.73) < 0.001 a, c, d, f
HMW adiponectin (μg/mL) †* 2.45 (2.18-2.75) 1.59 (1.43-1.77) 2.35 (2.11-2.62) 1.84 (1.65-2.05) < 0.001 a, c, d, f
Continuous data presented as mean (95% CI). Categorical data presented as n (%).
†Means are adjusted for age and sex. *Geometric means (95% CI).
The overall p-value: ethnic differences in continuous and categorical variables were explored by ANOVA and Chi-square tests, respectively. Post hoc pairwise
comparisons: ap < 0.05, Aboriginal vs. Chinese, bp < 0.05, Aboriginal vs. European, cp < 0.05, Aboriginal vs. South Asian, dp < 0.05, Chinese vs. European, ep < 0.05,
Chinese vs. South Asian, fp < 0.05, European vs. South Asian.
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and HMW adiponectin concentrations were significantly
inversely associated with all measures of adiposity
(BMI, WC, WHR, percent body fat, VAT, and SAT) after
adjustments for age, sex, ethnicity, education, smoking
status, physical activity and total dietary energy intakes
(Table 2). The strongest relationships were observed be-
tween WHR and ln total adiponectin [B (95% CI): -2.118
(−2.714, -1.523), P < 0.001], and between WHR and ln
HMW adiponectin concentrations [B (95% CI): -2.663
(−3.609, -1.717), P < 0.001].Table 2 Association between adiposity and adiponectin
ln total adiponectin
B (95% CI) Standardized B p valu
BMI −0.021 (−0.030, -0.013) −0.191 < 0.00
WC −0.011 (−0.014, -0.007) −0.259 < 0.00
WHR −2.118 (−2.714, -1.523) −0.385 < 0.00
% BF −0.007 (−0.013, -0.001) −0.136 0.019
ln VAT −0.267 (−0.350, -0.184) −0.264 < 0.00
ln SAT −0.120 (−0.209, -0.031) −0.111 0.008
All linear regression models were adjusted for age, sex, ethnicity, formal level of ed
B, beta-value; BMI, body mass index; % BF, percent body fat; SAT, subcutaneous ad
waist-to-hip ratio.A significant inverse association between plasma total
adiponectin concentration and HOMA-IR was found
after adjustment for age, sex, ethnicity, family history of
diabetes mellitus, education, smoking status, physical ac-
tivity, dietary total energy intake, BMI, and WHR (Model
1) (Table 3). In this model, ethnicity had a significant effect
on HOMA-IR. Specifically, HOMA-IR was significantly
higher in South Asians compared to Europeans [B (95%
CI): 0.203 (0.087, 0.318), P = 0.001]. When the model was
further adjusted for VAT (Model 2, Table 3), the relation-
ship between plasma total adiponectin concentration andln HMW adiponectin
e B (95% CI) Standardized B p value
1 −0.035 (−0.048, -0.022) −0.199 < 0.001
1 −0.017 (−0.023, -0.011) −0.255 < 0.001
1 −2.663 (−3.609, -1.717) −0.305 < 0.001
−0.011 (−0.021, -0.002) −0.134 0.019
1 −0.339 (−0.471, -0.208) −0.210 < 0.001
−0.225 (−0.363, -0.086) −0.131 0.002
ucation, smoking status, physical activity, and energy intake.
ipose tissue; VAT, visceral adipose tissue; WC, waist circumference; WHR,
Table 3 Association between total adiponectin and
HOMA-IR
Outcome: in HOMA-IR Total adiponectin
B (95%CI) p value
Model 1
ln Total adiponectin −0.331 (−0.421, -0.242) < 0.001
Ethnicity
Aboriginal vs. European 0.001 (−0.126, 0.125) 0.995
Chinese vs. European 0.061 (−0.052, 0.174) 0.287
South Asian vs. European 0.203 (0.087, 0.318) 0.001
BMI 0.054 (0.043, 0.064) < 0.001
WHR 2.280 (1.530, 3.031) < 0.001
Model 2
ln Total adiponectin −0.300 (−0.385, -0.214) < 0.001
Ethnicity
Aboriginal vs. European 0.022 (−0.098, 0.141) 0.722
Chinese vs. European 0.061 (−0.046, 0.169) 0.264
South Asian vs. European 0.155 (0.044, 0.266) 0.006
BMI 0.030 (0.018, 0.041) < 0.001
WHR 1.251 (0.488, 2.013) 0.001
VAT 0.473 (0.351, 0.594) < 0.001
Outcome variable is ln HOMA-IR. Model 1 is adjusted for ethnicity, age, sex,
family history of diabetes, formal level of education, BMI, WHR, smoking status,
physical activity and energy intake. Model 2 = Model 1 + VAT.
BMI, body mass index; VAT, visceral adipose tissue; WHR, waist-to-hip ratio.
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cant [B (95% CI): -0.300 (−0.385, -0.214), P < 0.001].
The effect of ethnicity on HOMA-IR was also attenu-
ated with inclusion of VAT in the model; however,
HOMA-IR remained significantly higher in South
Asians compared to Europeans [B (95% CI): 0.155
(0.044, 0.266), P = 0.006] (Model 2, Table 3). While the
association between total adiponectin and HOMA-IR
was independent of ethnicity; ethnicity was found
to modify the relationship between plasma HMW adi-
ponectin concentration and HOMA-IR (Figure 1).
Compared to Europeans, the effect of HMW-adiponec-
tin on HOMA-IR was significantly different in Abo-
riginals (B (95% CI) = −0.238 (−0.391, -0.086), P = 0.002),
Chinese (B (95% CI) = −0.199 (−0.328, -0.069), P = 0.003,
and South Asians (B (95% CI) = −0.146 (−0.285, -0.008), P =
0.038). The addition of VAT did not substantially
change the modifying effect of ethnicity on the relation-
ship between HMW adiponectin and HOMA-IR.
Namely, after additional adjustment for VAT, the effect
of HMW-adiponectin on HOMA-IR in Aboriginals
(B (95% CI) = −0.236 (−0.381, -0.092), P = 0.001), Chinese
(B (95% CI) = −0.195 (−0.318, -0.072), P = 0.002), and
South Asians (B (95% CI) = −0.137 (−0.268, -0.006),
P = 0.040) was still significantly different from that of
Europeans.Discussion
The current study was designed to explore ethnic-
specific differences in the relationship between direct
measures of adiposity and plasma total and HMW adi-
ponectin concentrations in a multi-ethnic population of
Aboriginals, Chinese, Europeans, and South Asians. We
further determined whether ethnicity modifies the rela-
tionship of plasma total and HMW adiponectin concen-
trations with IR, independent of visceral adiposity. We
report that all measures of adiposity, surrogate (BMI,
WC, WHR) and direct (percent body fat, SAT, and
VAT), are inversely associated with plasma total and
HMW adiponectin concentrations but that ethnicity has
no effect on these relationships. We also found that
plasma total and HMW adiponectin concentrations are
inversely associated with HOMA-IR and that inclusion
of VAT in the model only slightly attenuated the rela-
tionship. Most interestingly, we found that ethnicity
modified the relationship between HMW adiponectin
and IR in that for every decrease in HMW adiponectin
concentration a greater increase in HOMA-IR was
observed in Aboriginals, Chinese, and South Asians than
in Europeans. This ethnic-specific effect was not ob-
served for the relationship between total adiponectin
and IR.
Adiponectin is an insulin-sensitizing adipocytokine that
may be a mediating factor that underlies ethnic-specific
differences in IR. Prior studies by others have been incon-
clusive [8-10,19,20] and little is known regarding the role
of body composition and body fat distribution in this rela-
tionship. We have previously reported that South Asians
and Aboriginals have significantly higher VAT deposition
compared to Chinese and Europeans [12] and this is ac-
companied by ethnic-differences in IR [21]. Most import-
antly, in the current study, we found that ethnicity
modifies the relationship between plasma HMW adipo-
nectin concentrations and HOMA-IR, in that for each
given decrease in plasma HMW adiponectin concentra-
tion, a greater increase in HOMA-IR was observed in
Aboriginals, Chinese, and South Asians compared to
Europeans. The same interaction was not observed for
plasma total adiponectin concentrations. Taken together
our findings suggest that HMW adiponectin may play a
role in the ethnic-specific differences in IR, which was pre-
viously attributed, in part, to ethnic-specific differences in
VAT deposition. Furthermore, the differences in HMW
adiponectin concentrations may also account for differ-
ences in diabetes severity and cardiovascular complications
observed among different indigenous populations [22].
As has been reported by others, our findings that eth-
nicity had no effect on the relationship between plasma
total and HMW adiponectin concentrations and surro-
gate measures of adiposity (BMI, WC, WHR), percent
body fat, and body fat distribution (VAT and SAT) is in
Figure 1 Interaction between plasma HMW adiponectin concentrations and ethnicity on HOMA-IR. The relationship between
HMW-adiponectin on HOMA-IR in Aboriginals (dashed line), Chinese (solid dark grey line) and South Asians (solid light grey line) is different from
that of Europeans (solid black line).
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reported an inverse relationship between surrogate mea-
sures of adiposity and plasma total adiponectin concen-
trations in Aboriginals, Chinese, and Europeans but not
in South Asians [10]. However, similar to our findings,
an inverse relationship between serum total adiponectin
concentrations and VAT was reported in a population of
South Asians living in California [19].
Adipose tissue is an endocrine organ that releases a
number of adipocytokines, such as leptin and adiponec-
tin, which play important roles in appetite regulation
and cellular energy metabolism [11]. In addition, adipo-
nectin has insulin-sensitizing functions and may contrib-
ute to ethnic-specific differences in IR. Similar to what
we report here, another group reported that plasma total
and HMW adiponectin concentrations were also lower
in South Asians compared to Europeans but an inverse
relationship with IR was only observed in Europeans
and not in South Asians [9]. Lower total adiponectin
concentrations were also reported in a population of
South Asians compared to African or Chinese subjects
from Trinidad [20]. In our current study we report the
opposite effect, with the strongest relationship between
plasma HMW adiponectin concentrations and IR found
in Aboriginals, Chinese, and South Asians compared to
Europeans. Interestingly, we did not find an ethnic-
specific effect on the relationship between plasma total
adiponectin concentrations and IR. This is in contrast to
the findings of another group that did report an effect of
ethnicity on the inverse relationship between plasma
total adiponectin concentrations and IR with South
Asians and Aboriginals showing the strongest relation-
ship compared to Europeans and Chinese [10].
The role of adiponectin in the maintenance of glucose-
insulin homeostasis has been investigated in the past two
decades. A study in isolated epididymal rat adipocytesincubated with globular recombinant adiponectin reported
that adiponectin facilitated insulin-stimulated glucose
uptake via the activation of AMP-kinase pathway [23]. A
study in male C57BL/6 J, ob/ob, and female non-obese
diabetic mice showed that an injection with 84 μg/g body
weight of recombinant full-length adiponectin reduced
serum glucose concentrations and subsequently reduced
hyperglycemia in the male ob/ob and female NOD mice
[24]. In the same study, it was also reported that the pres-
ence of 50 μg/mL of full-length adiponectin on isolated pri-
mary hepatocytes increased the ability of insulin to
suppress glucose production. Furthermore, variants in the
gene encoding one of the adiponectin receptors (ADIPOR2)
were reported to be associated with increased risk of devel-
oping type 2 diabetes and greater cardiovascular disease
risk factors in individuals with glucose intolerance [25].
In the current study we also considered body fat distri-
bution and specifically we were interested in investigating
the interplay between adiponectin and VAT as predictors
of HOMA-IR because of the evidence supporting a strong
inverse association between adiponectin and VAT [26-28].
A few studies have investigated whether adiponectin
synthesis and secretion is influenced by body fat location.
A study in adipose tissue explants obtained from subjects
undergoing abdominal surgery reported that total adipo-
nectin secretion by adipocytes from SAT explants was
lower in obese than in non-obese subjects but this was not
observed for adipocytes from VAT explants [29]. These
findings suggest that adiponectin secretion by adipose
tissue may depend on body fat location. In line with this,
we report that VAT has a stronger inverse association with
plasma total and HMW adiponectin concentrations than
SAT. In agreement with our findings, a study in cultured
adipocytes from human omental (VAT) adipose tissue and
SAT reported that adiponectin secretion by the omental
adipocytes was lower than that by SAT adipocytes [30].
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http://www.cardiab.com/content/12/1/170This study also reported that adiponectin secretion by the
omental adipocytes was increased in the presence insulin, an
effect that was but not observed in adipocytes from SAT,
further supporting a role for adiponectin and VAT in IR.Study limitations
Our study has some limitations. We used HOMA-IR
to assess IR, which is inferior to the euglycemic-
hyperinsulinemic clamp method to assess IR. However,
the use of HOMA-IR as a surrogate marker of IR is less
invasive and more feasible in large population studies
[18]. Furthermore, given our study is cross-sectional in
design we cannot determine the causal-effect of adipo-
nectin on HOMA-IR. Despite these limitations, our
study has strengths, which include our elaborate assess-
ment of adiponectin by quantifying plasma total and
HMW adiponectin concentrations. This is important
because HMW adiponectin is suggested to be the most
abundant and have the greatest insulin-sensitizing prop-
erties [6,7]. Furthermore, we included direct measures of
body fat distribution (VAT) in our models, which is
more strongly associated with IR compared to other
measures of adiposity [11]. Other limitations of our
study are the differences in age range and the relatively
small sample size of the different ethnic groups.
In summary, the relationship between plasma HMW
adiponectin and HOMA-IR is influenced by ethnicity
with the greater effect observed for Aboriginals, Chinese,
and South Asians compared to Europeans. Even after
adjustment for VAT, the association between adiponectin
and HOMA-IR remained significant, suggesting that adi-
ponectin plays a role in IR across different ethnic groups
independent of VAT.
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